Page results
-
This information leaflet is about longitudinal vaginal septums.
-
This patient information explains laparoscopic gonadectomy.
-
This patient information explains an inguinal gonadectomy.
-
This information explains what alpha thalassaemia is, and provides information about the different types of alpha thalassaemia.
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Clinical Biochemistry HSL at 60 Whitfield Street has a fully automated laboratory offering a range of routine biochemical tests to UCLH and local GPs.
-
The service offers a holistic, multidisciplinary approach to the evaluation and treatment of bladder, bowel and sexual dysfunction in individuals with established and suspected neurological disorders.
-
We provide a specialist spinal surgery service including treatment of degenerative spinal conditions, artificial discs, spinal injury, spinal tumours (intra and extra dural, including metastatic disease), scoliosis and syringomyelia.
-
The spasticity service at NHNN offers a comprehensive, responsive multidisciplinary service to adults with spasticity associated with any neurological condition.
File results
-
FOI/2022/0169 - Strategic workforce plan for recruitment and retention of Allied Health Professions
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients